Cargando…
QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs()()
INTRODUCTION: Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. PATIENTS AND METHODS: Paediatric patients affected from COVID-19 who received antivirals...
Autores principales: | Esmel-Vilomara, Roger, Dolader, Paola, Sabaté-Rotes, Anna, Soriano-Arandes, Antoni, Gran, Ferran, Rosés-Noguer, Ferran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U. on behalf of Asociación Española de Pediatría.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857946/ https://www.ncbi.nlm.nih.gov/pubmed/35193834 http://dx.doi.org/10.1016/j.anpede.2021.04.006 |
Ejemplares similares
-
Evolución del intervalo QTc en pacientes con infección SARS-CoV-2 tratados con fármacos antivirales()
por: Esmel-Vilomara, Roger, et al.
Publicado: (2022) -
Do we know the limits of the heart?
por: Figueras-Coll, Marc, et al.
Publicado: (2022) -
Flecainide intoxication in pediatric patients with supraventricular tachycardia
por: Vaquer, Guiem, et al.
Publicado: (2020) -
Case report: Removal of a subcutaneous implantable cardiac defibrillator in a pediatric patient with hypertrophic cardiomyopathy after a septal myectomy. Insights on current indications of type of ICD in children with hypertrophic cardiomyopathy and left ventricular tract obstruction
por: Dolader, Paola, et al.
Publicado: (2022) -
Differences between genetic dilated cardiomyopathy and myocarditis in children presenting with severe cardiac dysfunction
por: Gran, Ferran, et al.
Publicado: (2021)